<DOC>
	<DOCNO>NCT01341392</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic drug interaction CKD-501 amlodipine oral administration healthy male volunteer .</brief_summary>
	<brief_title>Drug-drug Interaction Study ( CKD-501 , Amlodipine )</brief_title>
	<detailed_description>Volunteers dose three time period CKD-501 0.5mg Amlodipine 10mg alone/co-administrate , repeat dos 10 day .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Between 20 age 45 year old healthy male Body weight ≥ 55kg 18.5 ≤ IBW &lt; 25 Agreement write informed consent Subject history affect ADME drug Hypersensitivity reaction drug clinically significant hypersensitivity reaction history party Inadequate subject medical examination ( medical history , physical examination , ECG , laboratory test ) AST , ALT &gt; UNL * 1.25 Total bilirubin &gt; UNL * 1.5 Estimated GFR ( MDRD ) &lt; 80 SBP &gt; 150 mmHg , SBP &lt; 100 mmHg DBP &gt; 100 mmHg , DBP &lt; 60 mmHg Pulse &gt; 100 per/min , Pulse &lt; 50 per/min Substance abuse , history drug abuse show positive party Continued take caffeine ( caffeine &gt; 5 cup/day ) , drink ( alcohol &gt; 210 g/week ) stop drinking severe heavy smoker ( cigarette &gt; 10 cigarette per day ) clinical trial Medication drugmediated induction/inhibition metabolic enzyme within 30 day may affect clinical trial Medication within 2 week first professional medical , medicine , OTC , vitamins take Subject take grapefruit within 1 month Previously participate trial within 60 day Previously donate whole blood within 60 day component blood within 30 day An impossible one participate clinical trial investigator 's decision include laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Drug-Drug interaction CKD-501 Amlodipine</keyword>
</DOC>